Commentary: Role of Bone-Modifying Agents in Metastatic Breast Cancer

by Hortobagyi, Gabriel N.
Published 2011

Toward Individualized Breast Cancer Therapy: Translating Biological Concepts to the Bedside

by Hortobagyi, Gabriel N.
Published 2012

Everolimus Plus Exemestane for the Treatment of Advanced Breast Cancer: A Review of Subanalyses from BOLERO-2()

by Hortobagyi, Gabriel N.
Published in Neoplasia (2015)

Ribociclib for the first-line treatment of advanced hormone receptor-positive breast cancer: a review of subgroup analyses from the MONALEESA-2 trial

by Hortobagyi, Gabriel N.
Published in Breast Cancer Res (2018)

Bernard Fisher: A Pioneer Moves On

by Hortobágyi, Gabriel N.
Published in Oncologist (2019)

Inflammatory breast cancer: Clinical progress and the main problems that must be addressed

by Giordano, Sharon H, Hortobagyi, Gabriel N
Published 2003

Prognostic molecular markers in early breast cancer

by Esteva, Francisco J, Hortobagyi, Gabriel N
Published 2004

Fingerprinting Lymph Node Metastases

by Symmans, W. Fraser, Hortobagyi, Gabriel N.
Published 2008

Dual human epidermal growth factor receptor 2 blockade for the treatment of HER2-positive breast cancer

by Alvarez, Ricardo H., Hortobagyi, Gabriel N.
Published 2013

Indirect Evaluation of Bone Saturation with Zoledronic Acid After Long‐Term Dosing

by Hortobagyi, Gabriel N., Zheng, Ming, Mohanlal, Ramon
Published in Oncologist (2018)

CDK4/6 inhibitors in hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer: Are we at the finish line?

by Yam, Clinton, Hung, Mien-Chie, Hortobagyi, Gabriel N.
Published in Oncotarget (2018)

Hot Flashes: A Review of Pathophysiology and Treatment Modalities

by Morrow, Phuong Khanh H., Mattair, Danielle N., Hortobagyi, Gabriel N.
Published 2011

Impact of Diabetes Mellitus on Complications and Outcomes of Adjuvant Chemotherapy in Older Patients With Breast Cancer

by Srokowski, Tomasz P., Fang, Shenying, Hortobagyi, Gabriel N., Giordano, Sharon H.
Published 2009

Overweight, Obesity, Diabetes, and Risk of Breast Cancer: Interlocking Pieces of the Puzzle

by La Vecchia, Carlo, Giordano, Sharon H., Hortobagyi, Gabriel N., Chabner, Bruce
Published 2011

First-cycle absolute neutrophil count can be used to improve chemotherapy-dose delivery and reduce the risk of febrile neutropenia in patients receiving adjuvant therapy: a validat...

by Rivera, Edgardo, Haim Erder, M, Fridman, Moshe, Frye, Debra, Hortobagyi, Gabriel N
Published 2003

Prognosis of Women With Metastatic Breast Cancer by HER2 Status and Trastuzumab Treatment: An Institutional-Based Review

by Dawood, Shaheenah, Broglio, Kristine, Buzdar, Aman U., Hortobagyi, Gabriel N., Giordano, Sharon H.
Published 2010

Gemcitabine Overcomes Erlotinib Resistance in EGFR-Overexpressing Cancer Cells through Downregulation of Akt

by Bartholomeusz, Chandra, Yamasaki, Fumiyuki, Saso, Hitomi, Kurisu, Kaoru, Hortobagyi, Gabriel N., Ueno, Naoto T.
Published 2011

Role of Epidermal Growth Factor Receptor in Breast Cancer

by Masuda, Hiroko, Zhang, Dongwei, Bartholomeusz, Chandra, Doihara, Hiroyoshi, Hortobagyi, Gabriel N., Ueno, Naoto T.
Published 2012

John Mendelsohn: A visionary scientist, oncologist and leader

by Kumar, Rakesh, Murad, Ferid, Bogler, Oliver, O'Malley, Bert W., Hortobagyi, Gabriel N.
Published in Genes Cancer (2019)

The PARP inhibitor AZD2281 (Olaparib) induces autophagy/mitophagy in BRCA1 and BRCA2 mutant breast cancer cells

by Arun, Banu, Akar, Ugur, Gutierrez-Barrera, Angelica M., Hortobagyi, Gabriel N., Ozpolat, Bulent
Published in Int J Oncol (2015)